Age at menarche and polycystic ovary syndrome: A Mendelian randomization study
International Journal of Gynecology & Obstetrics · 2023-09 · 162 (3) · 1050-1056
DOI: 10.1002/ijgo.14820 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 02.05.2023. Verfasst von Yuanlin Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-sun University, Guangzhou, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Guangzhou Science and Technology Project, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
The authors aimed to use a large two‐sample Mendelian randomization (MR) study to reveal the causality between age at menarche (AAM) and polycystic ovary syndrome (PCOS) incidence.
Methods
The authors collected summary statistics from the hitherto largest genome‐wide association studies conducted in AAM and PCOS in the same ancestry. MR with inverse variance weighting was conducted as the main analysis method, while weighted median and MR‐Egger regression were used for comprehensive analysis. As for pleiotropy detection, inverse variance weighting, MR‐Egger regression, Mendelian Randomization Pleiotropy Residual Sum and Outlier, as well as leave‐one‐out analysis were used to detect pleiotropy. Risk factor analysis was conducted to investigate the underlying mechanisms linking AAM to PCOS.
Results
Each standard deviation increment in AAM was associated with a significantly lower incidence of PCOS (odds ratio, 0.86 [95% confidence interval, 0.75–0.98]). After adjustment in horizontal pleiotropy by eliminating four outliers, this pathogenic association was still statistically detected. All pleiotropy indexes were without statistical differences, which suggested the conclusions were robust. It showed the causal association between later AAM and lower body mass index, lower fasting insulin level and insulin resistance.
Conclusion
Our MR analysis verified that a slightly later onset age (15 to 18 years) at menarche could reduce the risk of PCOS. A more comprehensive investigation in a prospective setting is strongly advised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-sun University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Reproductive Medicine, Guangzhou, China.
- Clinical Research Center for Obstetrical and Gynecological Diseases of Guangdong Province, Guangzhou, China.
- Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
- Reproductive Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Pulmonary and Critical Care Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Förderung
- Guangzhou Science and Technology Project
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- National Basic Research Program of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Ma, Y., Cai, J., Liu, L. W., Hou, W., Wei, Z., Wang, Y., & Xu, Y. (2023). Age at menarche and polycystic ovary syndrome: A Mendelian randomization study. International Journal of Gynecology & Obstetrics, 162(3), 1050-1056. https://doi.org/10.1002/ijgo.14820
Vancouver
Ma Y, Cai J, Liu LW, Hou W, Wei Z, Wang Y, et al. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study. International Journal of Gynecology & Obstetrics. 2023;162(3):1050-1056. doi:10.1002/ijgo.14820
BibTeX
@article{Ma2023,
author = {Ma, Yuanlin and Cai, Jiahao and Liu, Lok-Wan and Hou, Wenhui and Wei, Zixin and Wang, Yizi and Xu, Yanwen},
title = {Age at menarche and polycystic ovary syndrome: A Mendelian randomization study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {162},
number = {3},
pages = {1050--1056},
doi = {10.1002/ijgo.14820}
}
EUVIMED